These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37454041)

  • 1. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.
    Xie J; Liu Z; Ren L; He L; Lu S; Meng X; Zhang X; Su Z; Jing S; Shan T; Wang J; Xia R; Feng W; Li Y; Liu N; Liu Y
    BMC Public Health; 2023 Jul; 23(1):1361. PubMed ID: 37454041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
    Wei H; Ren J; Li R; Qi X; Yang F; Li Q
    Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040.
    Wei Y; Qin Z; Liao X; Zhou X; Huang H; Lan C; Qin W; Zhu G; Su H; Peng T
    Front Endocrinol (Lausanne); 2024; 15():1302436. PubMed ID: 39036051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019.
    Li C; Hua G; Liu S; Yu H; Yang X; Liu L
    Diabetes Metab Res Rev; 2024 May; 40(4):e3802. PubMed ID: 38634501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
    Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
    Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
    Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
    J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
    Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
    Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019.
    Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y
    Diabetes Metab Syndr; 2024 May; 18(5):103025. PubMed ID: 38851022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
    Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis.
    Wang C; Yang X; Zhang H; Zhang Y; Tao J; Jiang X; Wu C
    Front Public Health; 2023; 11():1225931. PubMed ID: 37575123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.
    Yang Z; Li A; Jiang Y; Maidaiti X; Wu Y; Jin Y
    Sci Rep; 2024 Sep; 14(1):22232. PubMed ID: 39333707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control.
    Bian Q; Zhang Y; Xue C; Lu W; Li W; Pan F; Li Y
    BMC Public Health; 2024 Mar; 24(1):782. PubMed ID: 38481192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study.
    Shu T; Tang M; He B; Liu X; Han Y; Liu C; Jose PA; Wang H; Zhang QW; Zeng C
    JMIR Public Health Surveill; 2024 Jan; 10():e46821. PubMed ID: 38265846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
    Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
    Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019.
    Wang M; Liu J; Wang J; Jin Y; Zheng ZJ
    J Diabetes; 2024 Mar; 16(3):e13499. PubMed ID: 38009553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019 study.
    Lin XL; Zhang QW; Chen GF; Yang SJ; Li XB; Deng WY
    Metabolism; 2024 Aug; 157():155954. PubMed ID: 38878856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national time trends in mortality for stroke, 1990-2019: An age-period-cohort analysis for the global burden of disease 2019 study and implications for stroke prevention.
    Peng S; Liu X; Cao W; Liu Y; Liu Y; Wang W; Zhang T; Guan X; Tang J; Zhang Q
    Int J Cardiol; 2023 Jul; 383():117-131. PubMed ID: 37150213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019.
    Cao F; Li DP; Wu GC; He YS; Liu YC; Hou JJ; Ni QY; Tao LM; Jiang ZX; Pan HF
    Ann Rheum Dis; 2024 Jan; 83(1):121-132. PubMed ID: 37666645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.
    Lou Z; Huang Y; Li S; Luo Z; Li C; Chu K; Zhang T; Song P; Zhou J
    BMC Public Health; 2023 May; 23(1):916. PubMed ID: 37208621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.